| ACUIX | DOXGX | ACUIX / DOXGX | |
| Total Expense Ratio | 1.78 | 0.41 | 434% |
| Annual Report Gross Expense Ratio | 1.78 | 0.46 | 387% |
| Fund Existence | 26 years | 4 years | - |
| Gain YTD | 14.750 | 3.912 | 377% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2000 | 2500 | 80% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.52B | 119B | 2% |
| Annual Yield % from dividends | 1.73 | 1.34 | 130% |
| Returns for 1 year | 19.67 | 18.54 | 106% |
| Returns for 3 years | 42.00 | 139.08 | 30% |
| Returns for 5 years | 24.81 | N/A | - |
| Returns for 10 years | 45.05 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| USAI | 46.03 | 0.23 | +0.50% |
| Pacer American Energy Infrastructure ETF | |||
| QMAR | 36.96 | 0.06 | +0.16% |
| FT Vest Nasdaq-100 Buffer ETF – Mar | |||
| GBIL | 100.02 | 0.02 | +0.02% |
| Goldman Sachs Access Treasury 0-1 Yr ETF | |||
| BLUI | 25.74 | -0.01 | -0.04% |
| Bluemonte Diversified Income ETF | |||
| BIS | 16.80 | -0.07 | -0.40% |
| ProShares UltraShort Nasdaq Biotech | |||